TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunities

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929

mTOR Signaling in Growth, Metabolism, and Disease

Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555

Protective and pathogenic functions of macrophage subsets

Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269

Liver fibrosis

Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958

Prevalence of Chronic Kidney Disease in the United States

Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895

Cellular and molecular mechanisms of fibrosis

Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495

Macrophages in Tissue Repair, Regeneration, and Fibrosis

Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481

Myofibroblasts and mechano-regulation of connective tissue remodelling

Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290

Burden of liver diseases in the world

Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783

PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., & Tomic‐Canic, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00410.x · Cited by 3,583

TGF-β: the master regulator of fibrosis

Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528

TGFβ signalling in context

Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128

AP-1 as a regulator of cell life and death

Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB

Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222

A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1

Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076

Idiopathic Pulmonary Fibrosis

Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056 · cited 4×

Molecular and cellular mechanisms of liver fibrosis and its regression

Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · cited 1×

Fibrotic disease and the TH1/TH2 paradigm

Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765

Formation and function of the myofibroblast during tissue repair

Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658

Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., & Sporn, M. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32345-7 · Cited by 1,598

The pathogenesis of cardiac fibrosis

Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567

Liver fibrosis

Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472

TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology

Morikawa, M., Derynck, R., & Miyazono, K. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021873 · Cited by 1,321

AP-1 subunits: quarrel and harmony among siblings

Hess, J., Angel, P., & Schorpp-Kistner, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01589 · Cited by 1,302

Transforming growth factor–β in tissue fibrosis

Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,272

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257

Mechanisms of Renal Fibrosis

Humphreys, B. D. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034227 · Cited by 1,231

Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., et al. (2012) · Science · doi:10.1126/science.1215135 · Cited by 1,199

Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis

Habermann, A. C., Gutierrez, A. J., Bui, L. T., Yahn, S. L., Winters, N. I., Calvi, C. L., Peter, L., Chung, M.-I., Taylor, C. J., Jetter, C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1972 · Cited by 1,129

Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., & Sporn, M. B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.119 · Cited by 1,094

Fibroblasts in fibrosis: novel roles and mediators

Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.

Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050

Fibroblasts and myofibroblasts in wound healing

Desmouliere, A., Darby, I. A., Laverdet, B., & Bonté, F. (2014) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s50046 · Cited by 1,039

TGFβ biology in cancer progression and immunotherapy

Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944

Genetic lineage tracing defines myofibroblast origin and function in the injured heart

Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892

TGF-β Signaling from Receptors to Smads

Hata, A., & Chen, Y.-G. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022061 · Cited by 888

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs

Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866

Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

Choo, A. Y., Yoon, S.-O., Kim, S. G., Roux, P. P., & Blenis, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809136105 · Cited by 810

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription

Zhang, Y., Feng, X.-H., & Derynck, R. (1998) · Nature · doi:10.1038/29814 · Cited by 809

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809

TGF-β1 Signaling and Tissue Fibrosis

Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800

Specificity, versatility, and control of TGF-β family signaling

Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785 · cited 10×

The mTOR pathway in the control of protein synthesis

Wang, X., & Proud, C. G. (2006) · Physiology · doi:10.1152/physiol.00024.2006 · Cited by 778

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.251 · Cited by 777

Spectrum of fibrotic lung diseases

Wijsenbeek, M., & Cottin, V. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2005230 · Cited by 736

Signaling Receptors for TGF-β Family Members

Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711

Non-Smad Signaling Pathways of the TGF-β Family

Zhang, Y. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022129 · Cited by 697

TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway

Hocevar, B. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 675

Shared and distinct mechanisms of fibrosis

Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637

TGF-β Family Signaling in the Control of Cell Proliferation and Survival

Zhang, Y., Alexander, P. B., & Wang, X.-F. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022145 · Cited by 626

Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases

Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614

Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn, M. B., & Roberts, A. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68561-8 · Cited by 601

Pulmonary fibrosis: patterns and perpetrators

Noble, P. W., Barkauskas, C. E., & Jiang, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60323 · Cited by 595

Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis

Xu, Y., Mizuno, T., Sridharan, A., Du, Y., Guo, M., Tang, J., Wikenheiser-Brokamp, K. A., Perl, A.-K. T., Funari, V. A., Gokey, J. J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90558 · Cited by 580

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Lipson, K. E., Wong, C., Teng, Y., & Spong, S. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 575

Epithelial-mesenchymal transition in tissue repair and fibrosis

Stone, R. C., Pastar, I., Ojeh, N., Chen, V., Liu, S., Garzon, K. I., & Tomic-Canic, M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2464-0 · Cited by 572

Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases

Rieder, F., Fiocchi, C., & Rogler, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.047 · Cited by 529

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

Lan, Y., Zhang, D., Xu, C., Hance, K. W., Marelli, B., Qi, J., Yu, H., Qin, G., Sircar, A., Hernández, V. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5488 · Cited by 494

Phase I study of GC1008 (fresolimumab): a human anti‐transforming growth factor‐beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma

Morris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090353 · Cited by 487

Determinants of Fibrosis Progression and Regression in NASH

Schuppan, D., Surabattula, R., & Wang, X. Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.012 · Cited by 479

TGF-β-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing

Schiller, M., Javelaud, D., & Mauviel, A. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2003.12.006 · Cited by 468

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.

Yang, E. Y., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.731 · Cited by 464

mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin

Kang, S. A., Pacold, M. E., Cervantes, C. L., Lim, D., Lou, H. J., Ottina, K., Gray, N. S., Turk, B. E., Yaffe, M. B., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1236566 · Cited by 431

Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation

Horan, G. S., Wood, S., Ona, V., Li, D. J., Lukashev, M. E., Weinreb, P. H., Simon, K. J., Hahm, K., Allaire, N. E., Rinaldi, N. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-805oc · Cited by 420

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice

Zhao, J., Shi, W., Wang, Y.-L., Chen, H., Bringas, P., Datto, M. B., Frederick, J. P., Wang, X.-F., & Warburton, D. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00151.2001 · Cited by 411

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Strauss, J., Heery, C. R., Schlom, J., Madan, R. A., Cao, L., Kang, Z., Lamping, E., Marté, J. L., Donahue, R. N., Grenga, I., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2653 · Cited by 406

Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404

Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404

Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins

Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403

Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts

Piek, E., Ju, W. J., Heyer, J., Escalante-Alcalde, D., Stewart, C. L., Weinstein, M., Deng, C., Kucherlapati, R., Böttinger, E. P., & Roberts, A. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102382200 · Cited by 397

Macrophages directly contribute collagen to scar formation during zebrafish heart regeneration and mouse heart repair

Simões, F. C., Cahill, T. J., Kenyon, A., Gavriouchkina, D., Vieira, J. M., Sun, X., Pezzolla, D., Ravaud, C., Masmanian, E., Weinberger, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14263-2 · Cited by 390

Tissue mechanics and fibrosis

Wells, R. G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.007 · Cited by 384

The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance

Burnham, E. L., Janssen, W. J., Riches, D. W. H., Moss, M., & Downey, G. P. (2014) · European Respiratory Journal · doi:10.1183/09031936.00196412 · Cited by 365

TGF-β Signaling in Control of Cardiovascular Function

Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases

Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M., & Ten Dijke, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102157 · Cited by 360

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

The UK-PSC Consortium, Ji, S.-G., The International IBD Genetics Consortium, The International PSC Study Group, Juran, B. D., Mucha, S., Folseraas, T., Jostins, L., Melum, E., Kumasaka, N., et al. (2017) · Nature Genetics · doi:10.1038/ng.3745 · Cited by 357

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Rice, L. M., Padilla, C. M., McLaughlin, S. R., Mathes, A., Ziemek, J., Goummih, S., Nakerakanti, S., York, M., Farina, G., Whitfield, M. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77958 · Cited by 351

Transcriptional Control by the SMADs

Hill, C. S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022079 · Cited by 351

Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis

Meng, X. M., Huang, X. R., Chung, A. C. K., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121244 · Cited by 338

Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis

Allen, R. J., Guillen-Guio, B., Oldham, J. M., Ma, S.-F., Dressen, A., Paynton, M. L., Kraven, L. M., Obeidat, M., Li, X., Ng, M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201905-1017oc · Cited by 329

Smads bind directly to the Jun family of AP-1 transcription factors

Liberati, N. T., Datto, M. B., Frederick, J. P., Shen, X., Wong, C., Rougier-Chapman, E. M., & Wang, X.-F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4844 · Cited by 327

β1 Integrin Inhibitory Antibody Induces Apoptosis of Breast Cancer Cells, Inhibits Growth, and Distinguishes Malignant from Normal Phenotype in Three Dimensional Cultures and In vivo

Park, C. C., Zhang, H., Pallavicini, M., Gray, J. W., Baehner, F., Park, C. J., & Bissell, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3071 · Cited by 326

Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction

Miyajima, A., Chen, J., Lawrence, C., Ledbetter, S., Soslow, R. A., Stern, J., Jha, S., Pigato, J., Lemer, M. L., Poppas, D. P., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00414.x · Cited by 321

Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex.

Kim, S. J., Angel, P., Lafyatis, R., Hattori, K., Kim, K. Y., Sporn, M. B., Karin, M., & Roberts, A. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1492 · Cited by 317

An AP-1 Binding Sequence Is Essential for Regulation of the Human α2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor-β

Chung, K.-Y., Agarwal, A., Uitto, J., & Mauviel, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3272 · Cited by 315

Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

Ng, B., Dong, J., D’Agostino, G., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Ko, N. S. J., Tan, J., Chothani, S. P., Huang, B., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1237 · Cited by 314

The α v β 1 integrin plays a critical in vivo role in tissue fibrosis

Reed, N. I., Jo, H., Chen, C., Tsujino, K., Arnold, T. D., DeGrado, W. F., & Sheppard, D. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5094 · Cited by 311

Fibrosis—a lethal component of systemic sclerosis

Ho, Y. Y., Lagares, D., Tager, A. M., & Kapoor, M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.53 · Cited by 306

Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation

Flanders, K. C., Sullivan, C. D., Fujii, M., Sowers, A., Anzano, M. A., Arabshahi, A., Major, C., Deng, C., Russo, A., Mitchell, J. B., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64926-7 · Cited by 285

Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors

Anderton, M. J., Mellor, H. R., Bell, A., Sadler, C., Pass, M., Powell, S., Steele, S. J., Roberts, R. R. A., & Heier, A. (2011) · Toxicologic Pathology · doi:10.1177/0192623311416259 · Cited by 284

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

Voelker, J., Berg, P. H., Sheetz, M., Duffin, K., Shen, T., Moser, B., Greene, T., Blumenthal, S. S., Rychlik, I., Yagil, Y., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111230 · Cited by 275

Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis

Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-806oc · Cited by 272

Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β

Wong, C., Rougier-Chapman, E. M., Frederick, J. P., Datto, M. B., Liberati, N. T., Li, J.-M., & Wang, X.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1821 · Cited by 261

Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor

Bonniaud, P., Margetts, P. J., Kolb, M., Schroeder, J. A., Kapoun, A. M., Damm, D., Murphy, A., Chakravarty, S., Dugar, S., Higgins, L., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-612oc · Cited by 256

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering

Ma, J., Sanchez-Duffhues, G., Goumans, M.-J., & ten Dijke, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00260 · Cited by 244

The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis

Murtha, L. A., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Knight, D. A., & Boyle, A. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00777 · Cited by 229

Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape

Martin, C. J., Datta, A., Littlefield, C., Kalra, A., Chapron, C., Wawersik, S., Dagbay, K. B., Brueckner, C. T., Nikiforov, A., Danehy, F. T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8456 · Cited by 224

The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis

Woodcock, H. V., Eley, J. D., Guillotin, D., Platé, M., Nanthakumar, C. B., Martufi, M., Peace, S., Joberty, G., Poeckel, D., Good, R. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07858-8 · Cited by 224

Myofibroblast differentiation and survival in fibrotic disease

Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

Liu, S. B., Ikenaga, N., Peng, Z., Sverdlov, D. Y., Greenstein, A., Smith, V., Schuppan, D., & Popov, Y. (2016) · The FASEB Journal · doi:10.1096/fj.14-268425 · Cited by 224

Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease

Peng, R., Sridhar, S., Tyagi, G., Phillips, J. E., Garrido, R., Harris, P., Burns, L., Renteria, L., Woods, J., Chen, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059348 · Cited by 222

β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts

Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6390 · Cited by 220

TGF-β1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: A fibronectin matrix-dependent event

Clark, R. A. F., McCoy, G. A., Folkvord, J. M., & McPherson, J. M. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199701)170:1<69::aid-jcp8>3.0.co;2-j · Cited by 217

Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.

Pertovaara, L., Sistonen, L., Bos, T. J., Vogt, P. K., Keski-Oja, J., & Alitalo, K. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1255 · Cited by 213

Integrin-mediated regulation of TGFβ in fibrosis

Henderson, N. C., & Sheppard, D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.005 · Cited by 210

Roles of mTOR complexes in the kidney: implications for renal disease and transplantation

Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B., & Thomson, A. W. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.108 · Cited by 208

Unifying mechanism for different fibrotic diseases

Wernig, G., Chen, S.-Y., Cui, L., Van Neste, C., Tsai, J. M., Kambham, N., Vogel, H., Natkunam, Y., Gilliland, D. G., Nolan, G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621375114 · Cited by 206

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

Purcell, J. W., Tanlimco, S. G., Hickson, J., Fox, M., Sho, M., Durkin, L., Uziel, T., Powers, R., Foster, K., McGonigal, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0327 · Cited by 205

Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression

Patsenker, E., Popov, Y., Stickel, F., Jonczyk, A., Goodman, S. L., & Schuppan, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.009 · Cited by 200

IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy

Moon, J.-A., Kim, H.-T., Cho, I.-S., Sheen, Y. Y., & Kim, D.-K. (2006) · Kidney International · doi:10.1038/sj.ki.5001775 · Cited by 197

The Role of p38α Mitogen-Activated Protein Kinase Activation in Renal Fibrosis

Stambe, C., Atkins, R. C., Tesch, G. H., Masaki, T., Schreiner, G. F., & Nikolic-Paterson, D. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000109669.23650.56 · Cited by 194

TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts

Vallée, A., & Lecarpentier, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0362-3 · Cited by 194

αvβ6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse

Hahm, K., Lukashev, M. E., Luo, Y., Yang, W. J., Dolinski, B. M., Weinreb, P. H., Simon, K. J., Chun Wang, L., Leone, D. R., Lobb, R. R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060158 · Cited by 190

Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis

Grygielko, E. T., Martin, W. M., Tweed, C., Thornton, P., Harling, J., Brooks, D. P., & Laping, N. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082099 · Cited by 190

Preclinical assessment of galunisertib (LY2157299 monohydrate), a first‐in‐class transforming growth factor‐β receptor type I inhibitor

Yingling, J. M., McMillen, W. T., Yan, L., Huang, H., Sawyer, J. S., Graff, J., Clawson, D. K., Britt, K. S., Anderson, B. D., Beight, D. W., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23795 · Cited by 187

Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family

Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187

Mechanisms of initiation and progression of intestinal fibrosis in IBD

Latella, G., Di Gregorio, J., Flati, V., Rieder, F., & Lawrance, I. C. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.968863 · Cited by 184

Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis

Wei, Y., Kim, T. J., Peng, D. H., Duan, D., Gibbons, D. L., Yamauchi, M., Jackson, J. R., Le Saux, C. J., Calhoun, C., Peters, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94624 · Cited by 184

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis

Lawrence, J., & Nho, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030778 · Cited by 183

Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation

Cook, S. A., & Schafer, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-041818-011649 · Cited by 181

A Milieu Molecule for TGF-β Required for Microglia Function in the Nervous System

Qin, Y., Garrison, B. S., Ma, W., Wang, R., Jiang, A., Li, J., Mistry, M., Bronson, R. T., Santoro, D., Franco, C., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.027 · Cited by 180

Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation

Chen, B., Huang, S., Su, Y., Wu, Y.-J., Hanna, A., Brickshawana, A., Graff, J., & Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.315069 · Cited by 180

The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis

Grimminger, F., Günther, A., & Vancheri, C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00149614 · Cited by 178

mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β 1 –induced collagen biosynthesis

Selvarajah, B., Azuelos, I., Platé, M., Guillotin, D., Forty, E. J., Contento, G., Woodcock, H. V., Redding, M., Taylor, A., Brunori, G., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav3048 · Cited by 172

p38 MAPK Pathway in the Heart: New Insights in Health and Disease

Romero-Becerra, R., Santamans, A., Folgueira, C., & Sabio, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197412 · Cited by 169

Signal integration in TGF-β, WNT, and Hippo pathways

Attisano, L., & Wrana, J. L. (2013) · F1000Prime Reports · doi:10.12703/p5-17 · Cited by 166

Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis

Wu, M.-J., Wen, M.-C., Chiu, Y.-T., Chiou, Y.-Y., Shu, K.-H., & Tang, M.-J. (2006) · Kidney International · doi:10.1038/sj.ki.5000161 · Cited by 164

Role of αvβ6 integrin in acute biliary fibrosis

Wang, B., Dolinski, B. M., Kikuchi, N., Leone, D. R., Peters, M. G., Weinreb, P. H., Violette, S. M., & Bissell, M. D. (2007) · Hepatology · doi:10.1002/hep.21849 · Cited by 163

EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling

Park, S.-A., Kim, M.-J., Park, S.-Y., Kim, J.-S., Lee, S., Woo, H. A., Kim, D.-K., Nam, J., & Sheen, Y. Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1798-6 · Cited by 162

TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders

Carthy, J. M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25879 · Cited by 161

MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation

Madala, S. K., Schmidt, S., Davidson, C. R., Ikegami, M., Wert, S. E., & Hardie, W. D. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0237oc · Cited by 159

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders

Gregorio, J. D., Robuffo, I., Spalletta, S., Giambuzzi, G., Iuliis, V. D., Toniato, E., Martinotti, S., Conti, P., & Flati, V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607483 · Cited by 158

Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation

Ju, W., Ogawa, A., Heyer, J., Nierhof, D., Yu, L., Kucherlapati, R., Shafritz, D. A., & Böttinger, E. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.654-667.2006 · Cited by 157

Macrophage Production of TGF‐β and Regulation by TGF‐β

Wahl, S. M., McCartney-Francis, N. L., Allen, J. B., Dougherty, E., & Dougherty, S. F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16111.x · Cited by 156

Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1.

Jiménez, S. A., Varga, J., Olsen, A. S., Li, L., Diaz, A., HERHAL, J., & Koch, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99930-8 · Cited by 156

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

Vincenti, F. G., Fervenza, F. C., Campbell, K. N., Encarnación, M. M. D., Gesualdo, L., Nelson, P., Praga, M., Radhakrishnan, J., Sellin, L. K., Singh, A. K., et al. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.03.011 · Cited by 153

Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity

Cui, L., Chen, S.-Y., Lerbs, T., Lee, J.-W., Domizi, P., Gordon, S., Kim, Y.-H., Nolan, G., Betancur, P., & Wernig, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16466-4 · Cited by 153

αv integrins: key regulators of tissue fibrosis

Conroy, K. P., Kitto, L. J., & Henderson, N. C. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2407-9 · Cited by 152

TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency

Chen, H., Chen, H., Liang, J., Gu, X., Zhou, J., Xie, C., Lv, X., Wang, R., Li, Q., Mao, Z., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0371-7 · Cited by 149

Diverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitro

Meng, X., Huang, X. R., Xiao, J., Chen, H., Zhong, X., Chung, A. C., & Lan, H. Y. (2011) · The Journal of Pathology · doi:10.1002/path.3976 · Cited by 148

Antibody-Mediated Blockade of Integrin αvβ6 Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β–Regulated Mechanism

Koopman Van Aarsen, L. A., Leone, D. R., Ho, S., Dolinski, B. M., McCoon, P. E., LePage, D. J., Kelly, R., Heaney, G., Rayhorn, P., Reid, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2307 · Cited by 146

Resident fibroblast expansion during cardiac growth and remodeling

Ivey, M. J., Kuwabara, J. T., Pai, J. T., Moore, R. E., Sun, Z., & Tallquist, M. D. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.11.012 · Cited by 146

Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)

Lacouture, M. E., Morris, J. C., Lawrence, D. P., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Berzofsky, J. A., Hsu, F. J., & Guitart, J. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-015-1653-0 · Cited by 145

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

Janse, M., Lamberts, L. E., Franke, L., Raychaudhuri, S., Ellinghaus, E., Boberg, K. M., Melum, E., Folseraas, T., Schrumpf, E., Bergquist, A. M., et al. (2011) · Hepatology · doi:10.1002/hep.24307 · Cited by 142

Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β

Yin, X., Choudhury, M., Kang, J. H., Schaefbauer, K. J., Jung, M.-Y., Andrianifahanana, M., Hernandez, D. M., & Leof, E. B. (2019) · Science Signaling · doi:10.1126/scisignal.aax4067 · Cited by 140

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β

Metelli, A., Wu, B. X., Riesenberg, B., Guglietta, S., Huck, J. D., Mills, C., Li, A., Rachidi, S., Krieg, C., Rubinstein, M. P., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay4860 · Cited by 139

TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis

Choi, M. E., Ding, Y., & Kim, S. I. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.003 · Cited by 138

Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals

Brigstock, D. R. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0071-5 · Cited by 137

Heterodimeric transforming growth factor beta. Biological properties and interaction with three types of cell surface receptors.

Cheifetz, S., Bassols, A., Stanley, K., Ohta, M., Greenberger, J. S., & Massagué, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38039-6 · Cited by 134

Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis

Si, M., Wang, Q., Li, Y., Lin, H., Luo, D., Zhao, W., Dou, X., Liu, J., Zhang, H., Huang, Y. L., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5341 · Cited by 134

An αv‐RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities

Hatley, R. J. D., Macdonald, S. J. F., Slack, R. J., Le, J., Ludbrook, S. B., & Lukey, P. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707948 · Cited by 133

Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis

John, A. E., Graves, R. H., Pun, K. T., Vitulli, G., Forty, E. J., Mercer, P. F., Morrell, J. L., Barrett, J. W., Rogers, R. F., Hafeji, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18397-6 · Cited by 131

Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts

Chen, G., Chen, H., Wang, C., Peng, Y., Sun, L., Liu, H., & Liu, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033626 · Cited by 131

Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction

Tan, S. M., Zhang, Y., Connelly, K. A., Gilbert, R. E., & Kelly, D. J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01048.2009 · Cited by 130

TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration

Chung, S., Overstreet, J. M., Li, Y., Wang, Y., Niu, A., Wang, S., Fan, X., Sasaki, K., Jin, G.-N., Khodo, S. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123563 · Cited by 128

Tyrosine kinase signaling in fibrotic disorders

Beyer, C., & Distler, J. H. W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.06.008 · Cited by 127

Spectrum of Fibrotic Lung Diseases

Karim, F., van Laar, J. A. M., & van Hagen, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2031135 · Cited by 127

Integrin αvβ8–expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells

Takasaka, N., Seed, R. I., Cormier, A., Bondesson, A. J., Lou, J., Elattma, A., Ito, S., Yanagisawa, H., Hashimoto, M., Ma, R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122591 · Cited by 119

Zeisberg, E.M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961

Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A. K., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Cited by 119

Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis

Peng, Z., Ikenaga, N., Liu, S. B., Sverdlov, D. Y., Vaid, K. A., Dixit, R., Weinreb, P. H., Violette, S., Sheppard, D., Schuppan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28274 · Cited by 118

Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment

Brown, N. F., & Marshall, J. F. (2019) · Cancers · doi:10.3390/cancers11091221 · Cited by 116

Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8

Stockis, J., Liénart, S., Colau, D., Collignon, A., Nishimura, S. L., Sheppard, D., Coulie, P. G., & Lucas, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710680114 · Cited by 111

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

Kovacs, R. J., Maldonado, G., Azaro, A., Fernández, M. S., Romero, F. L., Sepulveda-Sánchez, J. M., Corretti, M., Carducci, M., Dolan, M., Gueorguieva, I., et al. (2015) · Cardiovascular Toxicology · doi:10.1007/s12012-014-9297-4 · Cited by 108

Small airway fibrosis in COPD

Barnes, P. J. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105598 · Cited by 107

A Potent Pan-TGFβ Neutralizing Monoclonal Antibody Elicits Cardiovascular Toxicity in Mice and Cynomolgus Monkeys

Mitra, M. S., Lancaster, K., Adedeji, A. O., Palanisamy, G. S., Dave, R. A., Zhong, F., Holdren, M. S., Turley, S. J., Liang, W., Wu, Y., et al. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa024 · Cited by 107

Macrophages Produce TGF-β-Induced (β-ig-h3) following Ingestion of Apoptotic Cells and Regulate MMP14 Levels and Collagen Turnover in Fibroblasts

Nacu, N., Luzina, I. G., Highsmith, K., Lockatell, V., Pochetuhen, K., Cooper, Z. A., Gillmeister, M. P., Todd, N. W., & Atamas, S. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5036 · Cited by 104

Drugs and Targets in Fibrosis

Li, X., Zhu, L., Wang, B., Yuan, M., & Zhu, R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00855 · Cited by 103

Inhibition of activin receptor-like kinase 5 attenuates Bleomycin-induced pulmonary fibrosis

Higashiyama, H., Yoshimoto, D., Kaise, T., Matsubara, S., Fujiwara, M., Kikkawa, H., Asano, S., & Kinoshita, M. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.12.003 · Cited by 102

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood

Decaris, M. L., Li, K. W., Emson, C. L., Gatmaitan, M., Liu, S., Wang, Y., Nyangau, E., Colangelo, M., Angel, T. E., Beysen, C., et al. (2016) · Hepatology · doi:10.1002/hep.28860 · Cited by 101

Induction of the AP-1 members c-Jun and JunB by TGF-β/Smad suppresses early Smad-driven gene activation

Verrecchia, F., Tacheau, C., Schorpp‐Kistner, M., Angel, P. E., & Mauviel, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204347 · Cited by 100

Posttranslational Regulation of SmadsPreprint

Xu, P., Lin, X., & Feng, X. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022087 · Cited by 97

Combining TGF-β inhibition and angiotensin II blockade results in enhanced antifibrotic effect

Yu, L. H., Border, W. A., Anderson, I., Mccourt, M., Huang, Y., & Noble, N. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00901.x · Cited by 95

Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis

Li, J., Ren, J., Liu, X., Jiang, L., He, W., Yuan, W., Yang, J., & Dai, C. (2015) · Kidney International · doi:10.1038/ki.2015.119 · Cited by 95

Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease

Minagawa, S., Lou, J., Seed, R. I., Cormier, A., Wu, S., Cheng, Y., Murray, L., Tsui, P., Connor, J., Herbst, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008074 · Cited by 90

C-Jun-NH2-Terminal Kinase Mediates Expression of Connective Tissue Growth Factor Induced by Transforming Growth Factor-β1 in Human Lung Fibroblasts

Utsugi, M., Dobashi, K., Ishizuka, T., Masubuchi, K., Shimizu, Y., Nakazawa, T., & Mori, M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4892 · Cited by 89

Transforming growth factor‐beta type 1 receptor (ALK5) and Smad proteins mediate TIMP‐1 and collagen synthesis in experimental intestinal fibrosis

Medina, C., Santos-Martínez, M. J., Santana, A., Paz‐Cabrera, M. C., Johnston, M. J. G., Mourelle, M., Salas, A., & Guarner, F. (2011) · The Journal of Pathology · doi:10.1002/path.2870 · Cited by 89

Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis

Makino, K., Makino, T., Stawski, L., Lipson, K. E., Leask, A., & Trojanowska, M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1356-3 · Cited by 88

Transforming Growth Factor-β Stimulates Interleukin-11 Transcription via Complex Activating Protein-1-dependent Pathways

Tang, W., Yang, L., Yang, Y., Leng, S. X., & Elias, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5506 · Cited by 85

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Fu, K., Corbley, M. J., Sun, L., Friedman, J. E., Shan, F., Papadatos, J. L., Costa, D. E., Lutterodt, F., Sweigard, H., Bowes, S., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158030 · Cited by 85

Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis

Hurrell, T., Kastrinou‐Lampou, V., Fardellas, A., Hendriks, D. F. G., Nordling, Å., Johansson, I., Baze, A., Parmentier, C., Richert, L., & Ingelman‐Sundberg, M. (2020) · Cells · doi:10.3390/cells9040964 · Cited by 85

Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case–control study

Abramson, M. J., Murambadoro, T., Alif, S. M., Benke, G., Dharmage, S. C., Glaspole, I., Hopkins, P. M.-A., Hoy, R. F., Klebe, S., Moodley, Y. P., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214478 · Cited by 85

Epithelial–Mesenchymal Interactions in Fibrosis and Repair. Transforming Growth Factor-β Activation by Epithelial Cells and Fibroblasts

Sheppard, D. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201406-245mg · Cited by 83

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience

Dolmazashvili, E., Abutidze, A., Chkhartishvili, N., Karchava, M., Sharvadze, L., & Tsertsvadze, T. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000964 · Cited by 82

Fibroblasts and Their Pathological Functions in the Fibrosis of Aortic Valve Sclerosis and Atherosclerosis

Singh, S., & Torzewski, M. (2019) · Biomolecules · doi:10.3390/biom9090472 · Cited by 82

LOXL2—A New Target in Antifibrogenic Therapy?

Puente, A., Fortea, J. I., Cabezas, J., Arias Loste, M. T., Iruzubieta, P., Llerena, S., Huelin, P., Fábrega, E., & Crespo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071634 · Cited by 79

Deleting the TGF-β Receptor Attenuates Acute Proximal Tubule Injury

Gewin, L. S., Vadivelu, S., Neelisetty, S., Srichai, M. B., Paueksakon, P., Pozzi, A., Harris, R. C., & Zent, R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020139 · Cited by 78

Profibrotic up‐regulation of glucose transporter 1 by TGF‐β involves activation of MEK and mammalian target of rapamycin complex 2 pathways

Andrianifahanana, M., Hernandez, D. M., Yin, X., Kang, J. H., Jung, M., Wang, Y., Yi, E. S., Roden, A. C., LIMPER, A. H., & Leof, E. B. (2016) · The FASEB Journal · doi:10.1096/fj.201600428r · Cited by 78

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis

Platé, M., Guillotin, D., & Chambers, R. C. (2020) · European Respiratory Review · doi:10.1183/16000617.0269-2020 · Cited by 75

Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary Fibrosis

Chapman, H. A., Wei, Y., Montas, G., Leong, D., Golden, J. A., Trinh, B. N., Wolters, P. J., Saux, C. J. L., Jones, K. D., Hills, N. K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc1915189 · Cited by 73

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

Maher, T. M., Simpson, J. K., Porter, J. C., Wilson, F. J., Chan, R. H., Eames, R., Cui, Y., Siederer, S. K., Parry, S., Kenny, J. D., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01339-7 · Cited by 73

Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective

Gerarduzzi, C., & Battista, J. A. D. (2016) · Inflammation Research · doi:10.1007/s00011-016-1019-x · Cited by 72

Fibroblast‐specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease

Ng, B., Dong, J., Viswanathan, S., Widjaja, A. A., Paleja, B. S., Adami, E., Ko, N. S. J., Wang, M., Lim, S., Tan, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001045rr · Cited by 72

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study

Jung, S. Y., Hwang, S., Clarke, J. M., Bauer, T. M., Keedy, V. L., Lee, H., Park, N., Kim, S.-J., & Lee, J. I. (2020) · Investigational New Drugs · doi:10.1007/s10637-019-00835-y · Cited by 69

TGF-β1 Up-Regulates Connective Tissue Growth Factor Expression in Human Granulosa Cells through Smad and ERK1/2 Signaling Pathways

Cheng, J., Chang, H., Fang, L., Sun, Y., & Leung, P. C. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126532 · Cited by 65

Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure: A Cardiovascular Magnetic Resonance Study

Gulati, A., Japp, A. G., Raza, S., Halliday, B. P., Jones, D. A., Newsome, S., Ismail, N. A., Morarji, K., Khwaja, J., Spath, N. B., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.118.007722 · Cited by 65

Role of GARP in the activation of latent TGF-β1

Stockis, J., Dedobbeleer, O., & Lucas, S. (2017) · Molecular BioSystems · doi:10.1039/c7mb00251c · Cited by 63

Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis

Fang, D., Chen, B., Lescoat, A., Khanna, D., & Mu, R. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00864-7 · Cited by 84

PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells

Reininger, D., Fundel‐Clemens, K., Mayr, C. H., Wollin, L., Laemmle, B., Quast, K., Nickolaus, P., & Herrmann, F. E. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17303 · Cited by 48

Inhibition of TGFβ1 activation prevents radiation-induced lung fibrosis

Yi, M., Yuan, Y., Ma, L., Li, L., Qin, W., Wu, B., Zheng, B., Liao, X., Hu, G., & Liu, B. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1546 · Cited by 33

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1

Yoon, I., Kim, S., Cho, M., You, K. A., Son, J., Lee, C., Suh, J. H., Bae, D., Kim, J. M., Oh, S., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216940 · Cited by 22

Positive and negative feedback regulation of the TGF-β1 explains two equilibrium states in skin aging

Haga, M., Iida, K., & Okada, M. (2024) · iScience · doi:10.1016/j.isci.2024.109708 · Cited by 19